Kementec Solutions A/S: Financial statements 2022
CVR: 25806735
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Kementec Solutions A/S (CVR 25806735) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 21,148,080 and a net result of DKK 5,393,508 compared with DKK 5,219,512 the year before. That is an increase of 7.2% compared with the year before. Equity in the 2022 report amounted to DKK 22,430,875. The solvency ratio was 69.5%. The company had 20 employees in the financial year.
- Gross Profit
- DKK 21,148,080
- Profit/Loss
- DKK 5,393,508
- Equity
- DKK 22,430,875
- Total Assets
- DKK 32,265,101
- Employees
- 20
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 21.1 mio. | 5.4 mio. | 22.4 mio. | 20 |
| 2021 | - | 19.7 mio. | 5.2 mio. | 17 mio. | 18 |
| 2020 | - | 14.6 mio. | 1.7 mio. | 11.8 mio. | 18 |
| 2019 | - | 16.4 mio. | 4.1 mio. | 10.1 mio. | 19 |
| 2018 | - | 13.9 mio. | 2.8 mio. | 6 mio. | 18 |
Official annual report
Keep an eye on Kementec Solutions A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Kementec Solutions A/S has published its annual report for 2021. Gross profit came to DKK 19,725,204, and the net result was DKK 5,219,512.
About Kementec Solutions A/S
Kementec Solutions A/S is a Danish company of the type Aktieselskab based in Taastrup, founded in 2000. The company is registered under the industry Fremstilling af andre kemiske produkter i.a.n.. The company was previously named KEM-EN-TEC DIAGNOSTICS A/S. The management consists of Elaine Antonette Lundberg and Tobias Greve-Vilby. The board consists of Frank Vitzthum (chair), Christian Moraeno Dreher and Ute Salzbrenner. The company is owned by R-Biopharm AG. The company has 20 employees (2026). In 2025, the company reported a gross profit of DKK 18,706,173 and a net result of DKK 2,269,339 compared with DKK 1,565,137 the year before. Equity in the 2025 report amounted to DKK 25,366,459.